The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)
The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)
Active, not recruiting · NCT04207944 · Registry updated 2026-09-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Pancreatic Intraductal Neoplasms, Pancreatic Intraductal Papillary Mucinous Neoplasm, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic intraductal papillary-mucinous neoplasm, pancreatic neoplasm | Active, not recruiting | Phase 2 | 2026-09-08 | NCT04207944 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Duke University | 446 |
| Johns Hopkins University | 579 |
| Massachusetts General Hospital | 758 |
| Memorial Sloan Kettering Cancer Center | 753 |
| National Cancer Institute (NCI) | 3015 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Duke University Medical Center | Durham | United States | 505 |
| Johns Hopkins University | Baltimore | United States | 150 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| Memorial Sloan Kettering | New York | United States | 5 |